封面
市場調查報告書
商品編碼
1548167

全球輔助生殖技術市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Assisted Reproductive Technology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

全球輔助生殖技術市場需求預計將從2023年的330.5億美元達到近587億美元的市場規模,2024-2032年研究期間複合年成長率為6.59%。

輔助生殖技術 (ART) 是指一系列用於解決不孕症和幫助個人懷孕的醫療程序。 ART 包括體外受精 (IVF)、胞漿內單一精子注射 (ICSI) 以及配子或胚胎冷凍保存等技術。這些方法涉及在體外操縱卵子、精子和胚胎,以提高懷孕的機會。 ART 用於傳統受孕方法因精子數量低、輸卵管阻塞或與年齡相關的生育問題等因素而失敗的情況。 ART 領域取得了重大進展,提高了成功率,並為患有不孕症的個人和夫妻提供了新的選擇。

市場動態

生活方式的改變、生育延遲和生殖疾病盛行率上升導致不孕率上升,推動了輔助生殖技術市場的發展。例如,美國生殖醫學會強調,全球約有 10-15% 的夫婦患有不孕症。技術進步,例如體外受精技術的改進和基因篩檢工具的開發,為提高成功率和個人化治療提供了新的機會。此外,不同族群對 ART 治療的認知和接受程度不斷提高,也導致需求不斷成長。旨在支持不孕症治療和研究的政府措施和資金進一步促進輔助生殖技術市場的成長。這些促進因素和機會共同增強了市場發展和創新的潛力。然而,高昂的治療成本和倫理問題可能會限制輔助生殖技術市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球輔助生殖技術市場的各個細分市場進行了包容性評估。輔助生殖技術產業的成長和趨勢為本研究提供了整體方法。

市場區隔

輔助生殖技術市場報告的這一部分提供了國家和區域層面細分市場的詳細資料,從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按類型

  • 體外受精 (IVF)(新鮮供體、冷凍供體、新鮮非供體、冷凍非供體)
  • 人工授精(子宮內授精、子宮頸內授精、陰道內授精、輸卵管內授精)
  • 最終用途
  • 生育診所及其他設施
  • 醫院及其他

區域分析

本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲輔助生殖技術市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。輔助生殖技術市場的主要參與者包括 Cosmos Biomedical、Microm UK Ltd.、Origio (CooperSurgical)、Irvine Scientific、Cryolab Ltd.、Parallabs、歐洲精子庫、Bloom IVF 中心。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章:前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章:執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章:輔助生殖技術 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按類型分類的市場吸引力分析
    • 市場吸引力分析:按地區

第 4 章:價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章:全球輔助生殖技術市場分析:按類型

  • 按類型概述
  • 按類型分析歷史和預測數據
  • 體外受精 (IVF)(新鮮供體、冷凍供體、新鮮非供體、冷凍非供體)
  • 人工授精(子宮內授精、子宮頸內授精、陰道內授精、輸卵管內授精)
  • 最終用途
  • 生育診所及其他設施
  • 醫院及其他

第 6 章:全球輔助生殖技術市場分析:依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 7 章:輔助生殖科技公司的競爭格局

  • 輔助生殖技術市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 8 章:公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Cosmos Biomedical
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Microm UK Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Origio (CooperSurgical)
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Irvine Scientific
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Cryolab Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Parallabs
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • European Sperm Bank
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Bloom IVF Centre
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中,財務詳細資料和最新進展視情況而定,或對私人公司而言可能不包括在內

Product Code: VMR112115483

The global demand for Assisted Reproductive Technology Market is presumed to reach the market size of nearly USD 58.7 Billion by 2032 from USD 33.05 Billion in 2023 with a CAGR of 6.59% under the study period 2024-2032.

Assisted reproductive technology (ART) refers to a range of medical procedures used to address infertility and assist individuals in conceiving a child. ART encompasses techniques such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and gamete or embryo cryopreservation. These methods involve manipulating eggs, sperm, and embryos outside the body to enhance the chances of pregnancy. ART is employed in cases where traditional conception methods are unsuccessful due to factors like low sperm count, blocked fallopian tubes, or age-related fertility issues. The field of ART has seen significant advancements, improving success rates and providing new options for individuals and couples struggling with infertility.

MARKET DYNAMICS

The assisted reproductive technology market is driven by increasing infertility rates, attributed to lifestyle changes, delayed childbearing, and rising prevalence of reproductive disorders. For instance, the American Society for Reproductive Medicine highlights that infertility affects approximately 10-15% of couples globally. Technological advancements, such as improved IVF techniques and the development of genetic screening tools, offer new opportunities for enhancing success rates and personalizing treatment. Moreover, rising awareness and acceptance of ART treatments across diverse populations contribute to growing demand. Government initiatives and funding aimed at supporting infertility treatments and research further bolster assisted reproductive technology market growth. These drivers and opportunities collectively enhance the potential for market development and innovation. However, high treatment costs and ethical concerns may restrain assisted reproductive technology market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Assisted Reproductive Technology. The growth and trends of Assisted Reproductive Technology industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Assisted Reproductive Technology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • In-Vitro Fertilization (IVF) (Fresh Donor, Frozen Donor, Fresh Non-Donor, Frozen Non-Donor)
  • Artificial Insemination (Intrauterine Insemination, Intracervical Insemination, Intravaginal Insemination, Intratubal Insemination)
  • End-Use
  • Fertility Clinics & Other Facilities
  • Hospitals & Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Assisted Reproductive Technology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Assisted Reproductive Technology market include Cosmos Biomedical, Microm U.K. Ltd., Origio (CooperSurgical), Irvine Scientific, Cryolab Ltd., Parallabs, European Sperm Bank, Bloom IVF Centre. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ASSISTED REPRODUCTIVE TECHNOLOGY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data Analysis By Type
  • 5.3. In-Vitro Fertilization (IVF) (Fresh Donor, Frozen Donor, Fresh Non-Donor, Frozen Non-Donor) Historic and Forecast Sales By Regions
  • 5.4. Artificial Insemination (Intrauterine Insemination, Intracervical Insemination, Intravaginal Insemination, Intratubal Insemination) Historic and Forecast Sales By Regions
  • 5.5. End-Use Historic and Forecast Sales By Regions
  • 5.6. Fertility Clinics & Other Facilities Historic and Forecast Sales By Regions
  • 5.7. Hospitals & Others Historic and Forecast Sales By Regions

6. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET ANALYSIS BY GEOGRAPHY

  • 6.1. Regional Outlook
  • 6.2. Introduction
  • 6.3. North America Sales Analysis
    • 6.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.3.2 North America By Segment Sales Analysis
    • 6.3.3 North America By Country Sales Analysis
    • 6.3.4 United States Sales Analysis
    • 6.3.5 Canada Sales Analysis
    • 6.3.6 Mexico Sales Analysis
  • 6.4. Europe Sales Analysis
    • 6.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.4.2 Europe By Segment Sales Analysis
    • 6.4.3 Europe By Country Sales Analysis
    • 6.4.4 United Kingdom Sales Analysis
    • 6.4.5 France Sales Analysis
    • 6.4.6 Germany Sales Analysis
    • 6.4.7 Italy Sales Analysis
    • 6.4.8 Russia Sales Analysis
    • 6.4.9 Rest Of Europe Sales Analysis
  • 6.5. Asia Pacific Sales Analysis
    • 6.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.5.2 Asia Pacific By Segment Sales Analysis
    • 6.5.3 Asia Pacific By Country Sales Analysis
    • 6.5.4 China Sales Analysis
    • 6.5.5 India Sales Analysis
    • 6.5.6 Japan Sales Analysis
    • 6.5.7 South Korea Sales Analysis
    • 6.5.8 Australia Sales Analysis
    • 6.5.9 South East Asia Sales Analysis
    • 6.5.10 Rest Of Asia Pacific Sales Analysis
  • 6.6. Latin America Sales Analysis
    • 6.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.6.2 Latin America By Segment Sales Analysis
    • 6.6.3 Latin America By Country Sales Analysis
    • 6.6.4 Brazil Sales Analysis
    • 6.6.5 Argentina Sales Analysis
    • 6.6.6 Peru Sales Analysis
    • 6.6.7 Chile Sales Analysis
    • 6.6.8 Rest of Latin America Sales Analysis
  • 6.7. Middle East & Africa Sales Analysis
    • 6.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.7.2 Middle East & Africa By Segment Sales Analysis
    • 6.7.3 Middle East & Africa By Country Sales Analysis
    • 6.7.4 Saudi Arabia Sales Analysis
    • 6.7.5 UAE Sales Analysis
    • 6.7.6 Israel Sales Analysis
    • 6.7.7 South Africa Sales Analysis
    • 6.7.8 Rest Of Middle East And Africa Sales Analysis

7. COMPETITIVE LANDSCAPE OF THE ASSISTED REPRODUCTIVE TECHNOLOGY COMPANIES

  • 7.1. Assisted Reproductive Technology Market Competition
  • 7.2. Partnership/Collaboration/Agreement
  • 7.3. Merger And Acquisitions
  • 7.4. New Product Launch
  • 7.5. Other Developments

8. COMPANY PROFILES OF ASSISTED REPRODUCTIVE TECHNOLOGY INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Market Concentration Rate
  • 8.3. Cosmos Biomedical
    • 8.3.1 Company Overview
    • 8.3.2 Company Revenue
    • 8.3.3 Products
    • 8.3.4 Recent Developments
  • 8.4. Microm U.K. Ltd.
    • 8.4.1 Company Overview
    • 8.4.2 Company Revenue
    • 8.4.3 Products
    • 8.4.4 Recent Developments
  • 8.5. Origio (CooperSurgical)
    • 8.5.1 Company Overview
    • 8.5.2 Company Revenue
    • 8.5.3 Products
    • 8.5.4 Recent Developments
  • 8.6. Irvine Scientific
    • 8.6.1 Company Overview
    • 8.6.2 Company Revenue
    • 8.6.3 Products
    • 8.6.4 Recent Developments
  • 8.7. Cryolab Ltd.
    • 8.7.1 Company Overview
    • 8.7.2 Company Revenue
    • 8.7.3 Products
    • 8.7.4 Recent Developments
  • 8.8. Parallabs
    • 8.8.1 Company Overview
    • 8.8.2 Company Revenue
    • 8.8.3 Products
    • 8.8.4 Recent Developments
  • 8.9. European Sperm Bank
    • 8.9.1 Company Overview
    • 8.9.2 Company Revenue
    • 8.9.3 Products
    • 8.9.4 Recent Developments
  • 8.10. Bloom IVF Centre
    • 8.10.1 Company Overview
    • 8.10.2 Company Revenue
    • 8.10.3 Products
    • 8.10.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (USD MN)
  • In-Vitro Fertilization (IVF) (Fresh Donor, Frozen Donor, Fresh Non-Donor, Frozen Non-Donor) Market Sales By Geography (USD MN)
  • Artificial Insemination (Intrauterine Insemination, Intracervical Insemination, Intravaginal Insemination, Intratubal Insemination) Market Sales By Geography (USD MN)
  • End-Use Market Sales By Geography (USD MN)
  • Fertility Clinics & Other Facilities Market Sales By Geography (USD MN)
  • Hospitals & Others Market Sales By Geography (USD MN)
  • Global Assisted Reproductive Technology Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Assisted Reproductive Technology Report
  • Market Research Process
  • Market Research Methodology
  • Global Assisted Reproductive Technology Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type (USD MN)
  • In-Vitro Fertilization (IVF) (Fresh Donor, Frozen Donor, Fresh Non-Donor, Frozen Non-Donor) Market Sales By Geography (USD MN)
  • Artificial Insemination (Intrauterine Insemination, Intracervical Insemination, Intravaginal Insemination, Intratubal Insemination) Market Sales By Geography (USD MN)
  • End-Use Market Sales By Geography (USD MN)
  • Fertility Clinics & Other Facilities Market Sales By Geography (USD MN)
  • Hospitals & Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.